Quantitative Investment Management’s United Therapeutics UTHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$992K Buy
+1,831
New +$1.03M 0.11% 227
2025
Q2
Sell
-3,063
Closed -$944K 470
2025
Q1
$944K Buy
+3,063
New +$1.05M 0.09% 187
2024
Q3
Sell
-1,954
Closed -$622K 447
2024
Q2
$622K Buy
+1,954
New +$517K 0.07% 209
2021
Q2
Sell
-2,017
Closed -$337K 605
2021
Q1
$337K Sell
2,017
-3,448
-63% -$575K 0.03% 393
2020
Q4
$829K Buy
+5,465
New +$717K 0.07% 273
2020
Q2
Sell
-9,455
Closed -$896K 695
2020
Q1
$896K Buy
9,455
+5,314
+128% +$505K 0.1% 224
2019
Q4
$364K Buy
+4,141
New +$364K 0.01% 559
2019
Q3
Sell
-53,000
Closed -$4.14M 781
2019
Q2
$4.14M Buy
53,000
+37,400
+240% +$3.5M 0.16% 166
2019
Q1
$1.83M Buy
+15,600
New +$1.82M 0.11% 256
2018
Q4
Sell
-2,800
Closed -$358K 833
2018
Q3
$358K Buy
+2,800
New +$346K 0.01% 483
2017
Q2
Sell
-65,600
Closed -$8.88M 907
2017
Q1
$8.88M Buy
+65,600
New +$9.94M 0.13% 209
2015
Q4
Sell
-10,600
Closed -$1.39M 850
2015
Q3
$1.39M Buy
+10,600
New +$1.7M 0.1% 240
2015
Q1
Sell
-2,800
Closed -$362K 748
2014
Q4
$362K Sell
2,800
-3,900
-58% -$503K 0.06% 313
2014
Q3
$861K Buy
+6,700
New +$691K 0.17% 110
2014
Q1
Sell
-7,900
Closed -$893K 743
2013
Q4
$893K Buy
7,900
+5,100
+182% +$460K 0.09% 214
2013
Q3
$220K Buy
+2,800
New +$205K 0.02% 493

Other funds holding UTHR

Quantitative Investment Management's UTHR Position: Q2 2026 in Review

Quantitative Investment Management opened a new position in United Therapeutics (UTHR) in Q2 2026: 1,831 shares worth $992K. The stake represents 0.11% of the portfolio and ranks #227 among its holdings. This is a return to the name: Quantitative Investment Management previously reported a position in UTHR as recently as Q1 2025.

Quantitative Investment Management first reported a position in UTHR in Q3 2013 and has held it in 16 quarters since. The position peaked at $8.88M in Q1 2017. 882 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Quantitative Investment Management held 1,831 shares of United Therapeutics worth $992K as of Q2 2026.
  • United Therapeutics was a new Quantitative Investment Management position in Q2 2026.
  • United Therapeutics made up 0.11% of Quantitative Investment Management's portfolio in Q2 2026, its #227 holding.
  • Quantitative Investment Management first reported a position in United Therapeutics in Q3 2013 and has held it in 16 quarters since.
  • Quantitative Investment Management's United Therapeutics position peaked at $8.88M in Q1 2017.
  • 882 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Quantitative Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.